Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro.

Matteucci C, Minutolo A, Pollicita M, Balestrieri E, Grelli S, D'Ettorre G, Vullo V, Bucci I, Luchini A, Aquaro S, Sinibaldi-Vallebona P, Macchi B, Perno CF, Mastino A, Garaci E.

Expert Opin Biol Ther. 2015 Jul;15 Suppl 1:83-100. doi: 10.1517/14712598.2015.1021677. Epub 2015 Jun 22.

PMID:
26094546
2.

Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection.

Mirabelli C, Surdo M, Van Hemert F, Lian Z, Salpini R, Cento V, Cortese MF, Aragri M, Pollicita M, Alteri C, Bertoli A, Berkhout B, Micheli V, Gubertini G, Santoro MM, Romano S, Visca M, Bernassola M, Longo R, De Sanctis GM, Trimoulet P, Fleury H, Marino N, Mazzotta F, Cappiello G, Spanò A, Sarrecchia C, Zhang JM, Andreoni M, Angelico M, Verheyen J, Perno CF, Svicher V.

J Infect. 2015 Mar;70(3):288-98. doi: 10.1016/j.jinf.2014.10.015. Epub 2014 Nov 6.

PMID:
25452041
3.

Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression.

Salpini R, Colagrossi L, Bellocchi MC, Surdo M, Becker C, Alteri C, Aragri M, Ricciardi A, Armenia D, Pollicita M, Di Santo F, Carioti L, Louzoun Y, Mastroianni CM, Lichtner M, Paoloni M, Esposito M, D'Amore C, Marrone A, Marignani M, Sarrecchia C, Sarmati L, Andreoni M, Angelico M, Verheyen J, Perno CF, Svicher V.

Hepatology. 2015 Mar;61(3):823-33. doi: 10.1002/hep.27604. Epub 2015 Jan 28.

PMID:
25418031
4.

Comparative replication capacity of raltegravir-resistant strains and antiviral activity of the new-generation integrase inhibitor dolutegravir in human primary macrophages and lymphocytes.

Pollicita M, Surdo M, Di Santo F, Cortese MF, Fabeni L, Fedele V, Malet I, Marcelin AG, Calvez V, Ceccherini-Silberstein F, Perno CF, Svicher V.

J Antimicrob Chemother. 2014 Sep;69(9):2412-9. doi: 10.1093/jac/dku144. Epub 2014 May 23.

PMID:
24860155
5.

Nucleotide polymorphisms in the 5'-UTR region of HCV can affect the ability of two widely used assays to assign an HCV genotype.

Pollicita M, Cento V, Paba P, Perno CF, Ciotti M.

J Virol Methods. 2013 Oct;193(1):205-8. doi: 10.1016/j.jviromet.2013.06.002. Epub 2013 Jun 19.

PMID:
23791962
6.

Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.

Salpini R, Alteri C, Cento V, Pollicita M, Micheli V, Gubertini G, De Sanctis GM, Visca M, Romano S, Sarrecchia C, Andreoni M, Angelico M, Parruti G, Svicher V, Perno CF.

J Med Virol. 2013 Jun;85(6):996-1004. doi: 10.1002/jmv.23567.

PMID:
23588725
7.

Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group.

Svicher V, Alteri C, Montano M, D'Arrigo R, Andreoni M, Angarano G, Antinori A, Antonelli G, Allice T, Bagnarelli P, Baldanti F, Bertoli A, Borderi M, Boeri E, Bon I, Bruzzone B, Callegaro AP, Capobianchi MR, Carosi G, Cauda R, Ceccherini-Silberstein F, Clementi M, Chirianni A, Colafigli M, D'Arminio Monforte A, De Luca A, Di Biagio A, Di Nicuolo G, Di Perri G, Di Pietro M, Di Santo F, Fabeni L, Fadda G, Galli M, Gennari W, Ghisetti V, Giacometti A, Gori C, Gori A, Gulminetti R, Leoncini F, Maffongelli G, Maggiolo F, Manca G, Gargiulo F, Martinelli C, Maserati R, Mazzotta F, Meini G, Micheli V, Monno L, Mussini C, Narciso P, Nozza S, Paolucci S, Pal G, Parisi S, Parruti G, Pignataro AR, Pollicita M, Quirino T, Re MC, Rizzardini G, Santangelo R, Scaggiante R, Sterrantino G, Turriziani O, Vatteroni ML, Vecchi L, Viscoli C, Vullo V, Zazzi M, Lazzarini A, Perno CF; DIVA group.

New Microbiol. 2012 Jan;35(1):17-25. Epub 2012 Jan 10.

8.

Comparative antiviral activity of integrase inhibitors in human monocyte-derived macrophages and lymphocytes.

Scopelliti F, Pollicita M, Ceccherini-Silberstein F, Di Santo F, Surdo M, Aquaro S, Perno CF.

Antiviral Res. 2011 Nov;92(2):255-61. doi: 10.1016/j.antiviral.2011.08.008. Epub 2011 Aug 16.

PMID:
21867733
9.

Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors.

Ceccherini-Silberstein F, Van Baelen K, Armenia D, Trignetti M, Rondelez E, Fabeni L, Scopelliti F, Pollicita M, Van Wesenbeeck L, Van Eygen V, Dori L, Sarmati L, Aquaro S, Palamara G, Andreoni M, Stuyver LJ, Perno CF.

Antimicrob Agents Chemother. 2010 Sep;54(9):3938-48. doi: 10.1128/AAC.01720-09. Epub 2010 May 17.

10.

Apoptosis and telomeres shortening related to HIV-1 induced oxidative stress in an astrocytoma cell line.

Pollicita M, Muscoli C, Sgura A, Biasin A, Granato T, Masuelli L, Mollace V, Tanzarella C, Del Duca C, Rodinò P, Perno CF, Aquaro S.

BMC Neurosci. 2009 May 22;10:51. doi: 10.1186/1471-2202-10-51.

11.

HIV-1-associated dementia during HAART therapy.

Aquaro S, Svicher V, Ronga L, Perno CF, Pollicita M.

Recent Pat CNS Drug Discov. 2008 Jan;3(1):23-33. Review.

PMID:
18221238
12.

Profound anti-HIV-1 activity of DAPTA in monocytes/macrophages and inhibition of CCR5-mediated apoptosis in neuronal cells.

Pollicita M, Ruff MR, Pert CB, Polianova MT, Schols D, Ranazzi A, Perno CF, Aquaro S.

Antivir Chem Chemother. 2007;18(5):285-95.

PMID:
18046961
13.

The contribution of peroxynitrite generation in HIV replication in human primary macrophages.

Aquaro S, Muscoli C, Ranazzi A, Pollicita M, Granato T, Masuelli L, Modesti A, Perno CF, Mollace V.

Retrovirology. 2007 Oct 21;4:76.

14.
15.

Telomerase activity, hTERT expression, and phosphorylation are downregulated in CD4(+) T lymphocytes infected with human immunodeficiency virus type 1 (HIV-1).

Franzese O, Adamo R, Pollicita M, Comandini A, Laudisi A, Perno CF, Aquaro S, Bonmassar E.

J Med Virol. 2007 May;79(5):639-46.

PMID:
17387751
16.

Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: evaluation of new 6-desfluoroquinolone derivatives.

Stevens M, Pollicita M, Pannecouque C, Verbeken E, Tabarrini O, Cecchetti V, Aquaro S, Perno CF, Fravolini A, De Clercq E, Schols D, Balzarini J.

Antimicrob Agents Chemother. 2007 Apr;51(4):1407-13. Epub 2007 Jan 22.

17.

Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies.

Aquaro S, Svicher V, Schols D, Pollicita M, Antinori A, Balzarini J, Perno CF.

J Leukoc Biol. 2006 Nov;80(5):1103-10. Epub 2006 Aug 24. Review.

18.

Therapeutic strategies towards HIV-1 infection in macrophages.

Perno CF, Svicher V, Schols D, Pollicita M, Balzarini J, Aquaro S.

Antiviral Res. 2006 Sep;71(2-3):293-300. Epub 2006 Jun 9. Review.

PMID:
16806514
19.

Human immunodeficiency virus infection and acquired immunodeficiency syndrome dementia complex: role of cells of monocyte-macrophage lineage.

Aquaro S, Ronga L, Pollicita M, Antinori A, Ranazzi A, Perno CF.

J Neurovirol. 2005;11 Suppl 3:58-66. Review.

PMID:
16540457
20.

Pharmacologic treatment of the dysfunctional patient.

Cardelli P, Lattari M, Massaro P, Pollicita M, Barlattani A.

Minerva Stomatol. 2005 May;54(5):265-79. Review. English, Italian.

PMID:
15985981
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk